1	Interferons	Interferon	_	_	_	_	_	_	_
2	induce	induce	_	_	_	_	_	_	_
3	normal	normal	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	aberrant	aberrant	_	_	_	_	_	_	_
6	retinoic-acid	retinoic-acid	_	_	_	_	_	_	_
7	receptors	receptor	_	_	_	_	_	_	_
8	type	type	_	_	_	_	_	_	_
9	alpha	alpha	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	acute	acute	_	_	_	_	_	_	_
12	promyelocytic	promyelocytic	_	_	_	_	_	_	_
13	leukemia	leukemia	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	:	:	_	_	_	_	_	_	_
16	potentiation	potentiation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	induction	induction	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	retinoid-dependent	retinoid-dependent	_	_	_	_	_	_	_
22	differentiation	differentiation	_	_	_	_	_	_	_
23	markers	marker	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	acute	acute	_	_	_	_	_	_	_
5	promyelocytic	promyelocytic	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	APL	APL	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	line	line	_	_	_	_	_	_	_
11	NB4	nb4	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	interferon	interferon	_	_	_	_	_	_	_
14	alpha	alpha	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	IFN(alpha))	IFN(alpha))	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	as	as	_	_	_	_	_	_	_
19	well	well	_	_	_	_	_	_	_
20	as	as	_	_	_	_	_	_	_
21	IFN(beta)	ifn(beta)	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	gamma	gamma	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	results	result	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	an	an	_	_	_	_	_	_	_
28	increased	increase	_	_	_	_	_	_	_
29	expression	expression	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	transcripts	transcript	_	_	_	_	_	_	_
33	coding	cod	_	_	_	_	_	_	_
34	for	for	_	_	_	_	_	_	_
35	retinoic-acid	retinoic-acid	_	_	_	_	_	_	_
36	receptor	receptor	_	_	_	_	_	_	_
37	type	type	_	_	_	_	_	_	_
38	alpha	alpha	_	_	_	_	_	_	_
39	(	(	_	_	_	_	_	_	_
40	RAR(alpha))	RAR(alpha))	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	the	the	_	_	_	_	_	_	_
43	leukemia-specific	leukemia-specific	_	_	_	_	_	_	_
44	retinoic	retinoic	_	_	_	_	_	_	_
45	acid	acid	_	_	_	_	_	_	_
46	receptor	receptor	_	_	_	_	_	_	_
47	PML-RAR	pml-rar	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	Transcriptional	transcriptional	_	_	_	_	_	_	_
2	induction	induction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	RAR(alpha)	rar(alpha)	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	PML-RAR	pml-rar	_	_	_	_	_	_	_
8	mRNAs	mrna	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	rapid	rapid	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	it	it	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	parallelled	parallel	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	an	an	_	_	_	_	_	_	_
17	increase	increase	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	corresponding	corresponding	_	_	_	_	_	_	_
21	proteins	protein	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Up-regulation	up-regulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	RAR(alpha)	RAR(alpha)	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	PML-RAR	PML-RAR	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	IFN(alpha)	IFN(alpha)	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	accompanied	accompany	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	strong	strong	_	_	_	_	_	_	_
15	potentiation	potentiation	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	induction	induction	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	2	2	_	_	_	_	_	_	_
21	retinoid-dependent	retinoid-dependent	_	_	_	_	_	_	_
22	granulocytic	granulocytic	_	_	_	_	_	_	_
23	markers	marker	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	i.e.	i.e.	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	granulocyte-colony-stimulating	granulocyte-colony-stimulating	_	_	_	_	_	_	_
28	factor	factor	_	_	_	_	_	_	_
29	receptor	receptor	_	_	_	_	_	_	_
30	mRNA	mrna	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	leukocyte	leukocyte	_	_	_	_	_	_	_
33	alkaline	alkaline	_	_	_	_	_	_	_
34	phosphatase	phosphatase	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	IFN(alpha)	IFN(alpha)	_	_	_	_	_	_	_
4	does	do	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	have	have	_	_	_	_	_	_	_
7	any	any	_	_	_	_	_	_	_
8	effects	effect	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	retinoid-dependent	retinoid-dependent	_	_	_	_	_	_	_
12	regulation	regulation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	myeloid	myeloid	_	_	_	_	_	_	_
16	surface	surface	_	_	_	_	_	_	_
17	markers	marker	_	_	_	_	_	_	_
18	CD11b	CD11b	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	CD33	CD33	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	IFN-dependent	ifn-dependent	_	_	_	_	_	_	_
3	increase	increase	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	RAR(alpha)	rar(alpha)	_	_	_	_	_	_	_
6	levels	level	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	enhancing	enhancing	_	_	_	_	_	_	_
10	effect	effect	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	cytokine	cytokine	_	_	_	_	_	_	_
14	on	on	_	_	_	_	_	_	_
15	retinoid-dependent	retinoid-dependent	_	_	_	_	_	_	_
16	granulocytic	granulocytic	_	_	_	_	_	_	_
17	markers	marker	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	may	may	_	_	_	_	_	_	_
20	be	be	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	characteristic	characteristic	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	PML-RAR	PML-RAR	_	_	_	_	_	_	_
25	positive	positive	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	since	since	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	phenomena	phenomenon	_	_	_	_	_	_	_
31	are	be	_	_	_	_	_	_	_
32	not	not	_	_	_	_	_	_	_
33	observed	observe	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	HL-60	HL-60	_	_	_	_	_	_	_
36	promyelocytes	promyelocyte	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Interferons	interferon	_	_	_	_	_	_	_
2	as	as	_	_	_	_	_	_	_
3	well	well	_	_	_	_	_	_	_
4	as	as	_	_	_	_	_	_	_
5	retinoids	retinoid	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	growth	growth	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	NB4	nb4	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	although	although	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	2	2	_	_	_	_	_	_	_
16	classes	class	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	compounds	compound	_	_	_	_	_	_	_
19	do	do	_	_	_	_	_	_	_
20	not	not	_	_	_	_	_	_	_
21	significantly	significantly	_	_	_	_	_	_	_
22	interact	interact	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	terms	term	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	anti-proliferative	anti-proliferative	_	_	_	_	_	_	_
27	activity	activity	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	possible	possible	_	_	_	_	_	_	_
6	use	use	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	combinations	combination	_	_	_	_	_	_	_
9	between	between	_	_	_	_	_	_	_
10	IFNs	ifn	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	retinoic	retinoic	_	_	_	_	_	_	_
13	acid	acid	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	cyto-differentiating	cyto-differentiating	_	_	_	_	_	_	_
17	treatment	treatment	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	APL	APL	_	_	_	_	_	_	_
20	patients	patient	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

